Impact of a Raltegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01837277
Recruitment Status : Unknown
Verified March 2015 by Carlos Brites, Fundação Bahiana de Infectologia.
Recruitment status was:  Not yet recruiting
First Posted : April 23, 2013
Last Update Posted : March 6, 2015
Information provided by (Responsible Party):
Carlos Brites, Fundação Bahiana de Infectologia

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2016
  Estimated Study Completion Date : March 2016